Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.

Induced pluripotent stem cells hold great potential to produce unlimited amount of differentiated cells as cellular source for regenerative medicine but also for in vitro drug screening and cytotoxicity tests. Ocular toxicity testing is mandatory to evaluate the risks of drugs and cosmetic products...

Full description

Bibliographic Details
Main Authors: Edith Aberdam, Isabelle Petit, Linda Sangari, Daniel Aberdam
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179913&type=printable
_version_ 1826579464794931200
author Edith Aberdam
Isabelle Petit
Linda Sangari
Daniel Aberdam
author_facet Edith Aberdam
Isabelle Petit
Linda Sangari
Daniel Aberdam
author_sort Edith Aberdam
collection DOAJ
description Induced pluripotent stem cells hold great potential to produce unlimited amount of differentiated cells as cellular source for regenerative medicine but also for in vitro drug screening and cytotoxicity tests. Ocular toxicity testing is mandatory to evaluate the risks of drugs and cosmetic products before their application to human patients by preventing eye irritation or insult. Since the global ban to use animals, many human-derived alternatives have been proposed, from ex-vivo enucleated postmortem cornea, primary corneal cell culture and immortalized corneal epithelial cell lines. All of them share limitations for their routine use. Using an improved protocol, we derived limbal epithelial cells from human induced pluripotent stem cells, named LiPSC, that are able to be passaged and differentiate further into corneal epithelial cells. Comparative RT-qPCR, immunofluorescence staining, flow cytometry analysis and zymography assays demonstrate that LiPSC are morphologically and molecularly similar to the adult stem cells. Moreover, contrary to HCE, LiPSC and primary limbal cells display similarly sensitive to cytotoxicity treatment among passages. Our data strongly suggest that LiPSC could become a powerful alternative cellular model for cosmetic and drug tests.
first_indexed 2024-12-10T20:33:00Z
format Article
id doaj.art-ec8f3329a0e5429194e2e63d7aeed605
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-14T14:18:42Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ec8f3329a0e5429194e2e63d7aeed6052025-02-27T05:32:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017991310.1371/journal.pone.0179913Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.Edith AberdamIsabelle PetitLinda SangariDaniel AberdamInduced pluripotent stem cells hold great potential to produce unlimited amount of differentiated cells as cellular source for regenerative medicine but also for in vitro drug screening and cytotoxicity tests. Ocular toxicity testing is mandatory to evaluate the risks of drugs and cosmetic products before their application to human patients by preventing eye irritation or insult. Since the global ban to use animals, many human-derived alternatives have been proposed, from ex-vivo enucleated postmortem cornea, primary corneal cell culture and immortalized corneal epithelial cell lines. All of them share limitations for their routine use. Using an improved protocol, we derived limbal epithelial cells from human induced pluripotent stem cells, named LiPSC, that are able to be passaged and differentiate further into corneal epithelial cells. Comparative RT-qPCR, immunofluorescence staining, flow cytometry analysis and zymography assays demonstrate that LiPSC are morphologically and molecularly similar to the adult stem cells. Moreover, contrary to HCE, LiPSC and primary limbal cells display similarly sensitive to cytotoxicity treatment among passages. Our data strongly suggest that LiPSC could become a powerful alternative cellular model for cosmetic and drug tests.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179913&type=printable
spellingShingle Edith Aberdam
Isabelle Petit
Linda Sangari
Daniel Aberdam
Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
PLoS ONE
title Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
title_full Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
title_fullStr Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
title_full_unstemmed Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
title_short Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing.
title_sort induced pluripotent stem cell derived limbal epithelial cells lipsc as a cellular alternative for in vitro ocular toxicity testing
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179913&type=printable
work_keys_str_mv AT edithaberdam inducedpluripotentstemcellderivedlimbalepithelialcellslipscasacellularalternativeforinvitrooculartoxicitytesting
AT isabellepetit inducedpluripotentstemcellderivedlimbalepithelialcellslipscasacellularalternativeforinvitrooculartoxicitytesting
AT lindasangari inducedpluripotentstemcellderivedlimbalepithelialcellslipscasacellularalternativeforinvitrooculartoxicitytesting
AT danielaberdam inducedpluripotentstemcellderivedlimbalepithelialcellslipscasacellularalternativeforinvitrooculartoxicitytesting